专利 Abandoned

COMPOSITIONS AND METHODS FOR TREATING MULTI-DRUG RESSISTANT MALARIA

专利「COMPOSITIONS AND METHODS FOR TREATING MULTI-DRUG RESSISTANT MALARIA」由 FEBRIS BIO-TECH LIMITED 持有,当前状态为Abandoned,申请号 P/280。LaoBiz 老商通提供老挝知识产权信息检索与企业关联查询。

Patent “COMPOSITIONS AND METHODS FOR TREATING MULTI-DRUG RESSISTANT MALARIA” is held by FEBRIS BIO-TECH LIMITED; status: Abandoned. Search Laos IP records on LaoBiz.

申请号 P/280
申请日期 2011-09-10
申请人 FEBRIS BIO-TECH LIMITED
代理机构 CONCETTI- Representative Bureau in LAOS.
类别 A61K 36/28

图样

下载

基础信息

类型
专利
申请号
P/280
状态
Abandoned
申请人
FEBRIS BIO-TECH LIMITED
代理机构
CONCETTI- Representative Bureau in LAOS.
申请日期
2011-09-10
公开/公告日
2025-12-05
国际分类
A61K 36/28
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz 企业数据库联动

摘要

A method is provided for treating individual for a malarial infection, in particular drug-resistant species of Plasmodium, including administering to the individual in need of such treatment a composition comprising an extract containing an effective amount of one or more anti-malarial di- or tri-terpene compounds. Potent and effective extracts containing the anti-malarial compound can be derived from Luo Han fruit and Stevia leaves, including combinations for the same, for the purpose of treating and preventing malarial in an inexpensive manner from readily available commodities. In one embodiment, the composition is administered orally in a solid or liquid indigestible form.

A method is provided for treating individual for a malarial infection, in particular drug-resistant species of Plasmodium, including administering to the individual in need of such treatment a composition comprising an extract containing an effective amount of one or more anti-malarial di- or tri-terpene compounds. Potent and effective extracts containing the anti-malarial compound can be derived from Luo Han fruit and Stevia leaves, including combinations for the same, for the purpose of treating and preventing malarial in an inexpensive manner from readily available commodities. In one embodiment, the composition is administered orally in a solid or liquid indigestible form.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种